GlassScriptPhysician profile
Whitney Dunn
NPI 1407274459
$2,868.00
in general payments reported to CMS, 2019-2025
19 companies · $383 in 2025
The $383 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $370 · 2020: $327 · 2021: $549 · 2022: $367 · 2023: $388 · 2024: $485 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,255.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,301.38 | 2019-2025 | |
| Pfizer INC. | $329.33 | 2019-2024 | |
| Roche Diagnostics Corporation | $224.78 | 2019-2020 | |
| Exact Sciences Corporation | $161.91 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $146.57 | 2019-2024 | Gardasil, Gardasil 9, Vaqta |
| Biogen, INC. | $118.20 | 2024-2025 | Zurzuvae |
| Organon LLC | $116.66 | 2022-2025 | Nexplanon |
| Mylan Pharmaceuticals INC. | $114.65 | 2019-2020 | |
| Therapeuticsmd, INC. | $91.30 | 2020-2021 | |
| Exeltis, USA INC. | $45.59 | 2024-2025 | Slynd |
| Coopersurgical, INC. | $39.77 | 2020-2025 | Paragard T 380a |
| Dysis Medical, INC. | $36.05 | 2020-2022 | |
| Seqirus USA INC | $27.13 | 2024 | Flucelvax |
| Bayer Healthcare Pharmaceuticals INC. | $24.27 | 2025 | |
| Mayne Pharma Commercial LLC | $21.62 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $19.55 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Millicent US INC | $18.04 | 2024 | Intrarosa, Femring |
| Ferring Pharmaceuticals INC. | $17.64 | 2019 | |
| Becton, Dickinson and Company | $13.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.